Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Bird flu, special controls: Influenza A subtype tests and reagents are officially Class II medical devices following the March 22 release of a final rule and special controls 1guidance document detailing the 510(k) requirements for such products. The Centers for Disease Control & Prevention won clearance for the first rapid H5 subtype test to help identify avian flu cases through an expedited de novo 510(k) application in February (2"The Gray Sheet" Feb. 6, 2006, p. 11). Several firms are developing avian flu tests, including Toronto-based Tm Bioscience...
You may also be interested in...
FDA’s Accelerated Review Of Flu Test Offers A Model For Future Products
FDA's rapid review of a laboratory test that can aid in the diagnosis of avian influenza demonstrates a pathway that could be used for the introduction of other much-needed diagnostics, the agency suggests
Concept Papers Seek Industry Input On Combo Product Issues
FDA seeks feedback on two concept papers offering preliminary thoughts on adverse event reporting and on the number of applications needed for a combination product
Device Use In Home Health Setting Surveyed As Part Of CDRH Strategic Plan
FDA is conducting a rapid-response survey on home health care products to identify key issues associated with medical devices used in the home setting